K

Karolinska Development AB
STO:KDEV

Watchlist Manager
Karolinska Development AB
STO:KDEV
Watchlist
Price: 1.21 SEK 0.17% Market Closed
Market Cap: 323.4m SEK
Have any thoughts about
Karolinska Development AB?
Write Note

Karolinska Development AB
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Karolinska Development AB
Total Equity Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
IRLAB A
I
FLERIE

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
K
Karolinska Development AB
STO:KDEV
Total Equity
kr1.2B
CAGR 3-Years
7%
CAGR 5-Years
34%
CAGR 10-Years
-1%
Calliditas Therapeutics AB
STO:CALTX
Total Equity
kr106.8m
CAGR 3-Years
-51%
CAGR 5-Years
-31%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Total Equity
kr2.9B
CAGR 3-Years
53%
CAGR 5-Years
44%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Total Equity
kr7.7B
CAGR 3-Years
52%
CAGR 5-Years
132%
CAGR 10-Years
N/A
IRLAB Therapeutics AB
STO:IRLAB A
Total Equity
kr115.8m
CAGR 3-Years
-31%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Total Equity
kr4.4B
CAGR 3-Years
108%
CAGR 5-Years
172%
CAGR 10-Years
N/A

See Also

What is Karolinska Development AB's Total Equity?
Total Equity
1.2B SEK

Based on the financial report for Jun 30, 2024, Karolinska Development AB's Total Equity amounts to 1.2B SEK.

What is Karolinska Development AB's Total Equity growth rate?
Total Equity CAGR 10Y
-1%

Over the last year, the Total Equity growth was 0%. The average annual Total Equity growth rates for Karolinska Development AB have been 7% over the past three years , 34% over the past five years , and -1% over the past ten years .

Back to Top